These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 11757206)
21. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy. Kawada K; Minami H; Okabe K; Watanabe T; Inoue K; Sawamura M; Yagi Y; Sasaki T; Takashima S Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601 [TBL] [Abstract][Full Text] [Related]
22. Therapy of malignancy-associated hypercalcemia: 1983. Stewart AF Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580 [TBL] [Abstract][Full Text] [Related]
23. Treatment of hypercalcemia of malignancy with bisphosphonates. Berenson JR Semin Oncol; 2002 Dec; 29(6 Suppl 21):12-8. PubMed ID: 12584690 [TBL] [Abstract][Full Text] [Related]
24. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia. Sekine M; Takami H Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321 [TBL] [Abstract][Full Text] [Related]
25. [Hypercalcemia as an emergency]. Rosenmund A Schweiz Med Wochenschr; 1993 Apr; 123(15):735-8. PubMed ID: 8488377 [TBL] [Abstract][Full Text] [Related]
26. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages. Nussbaum SR; Younger J; Vandepol CJ; Gagel RF; Zubler MA; Chapman R; Henderson IC; Mallette LE Am J Med; 1993 Sep; 95(3):297-304. PubMed ID: 8368227 [TBL] [Abstract][Full Text] [Related]
27. Hypercalcemia of malignancy remains a clinically relevant problem. Van Poznak C Cancer J; 2006; 12(1):21-3. PubMed ID: 16613658 [No Abstract] [Full Text] [Related]
28. Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy. Khan AA; Gurnani PK; Peksa GD; Whittier WL; DeMott JM Ann Pharmacother; 2021 Mar; 55(3):277-285. PubMed ID: 32885992 [TBL] [Abstract][Full Text] [Related]
29. Hypercalcaemia due to malignancy. Role of the kidney and treatment. Sleeboom HP; Bijvoet OL Contrib Nephrol; 1982; 33():178-96. PubMed ID: 6214375 [No Abstract] [Full Text] [Related]
30. Hypercalcemia: an evidence-based approach to clinical cases. Assadi F Iran J Kidney Dis; 2009 Apr; 3(2):71-9. PubMed ID: 19395781 [TBL] [Abstract][Full Text] [Related]
31. Newer agents for the treatment of malignant hypercalcemia. Kinirons MT Am J Med Sci; 1993 Jun; 305(6):403-6. PubMed ID: 8506902 [TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and management of cancer associated hypercalcaemia. Ralston SH Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993 [TBL] [Abstract][Full Text] [Related]
35. Treatment of cancer-related hypercalcemia: the role of gallium nitrate. Leyland-Jones B Semin Oncol; 2003 Apr; 30(2 Suppl 5):13-9. PubMed ID: 12776255 [TBL] [Abstract][Full Text] [Related]